Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$574,746
+$438,764 QoQ
Shares Held
108,648
+199.6% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ACRS ranks #175 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ACRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $574,746 | 108,648 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $135,982 | 36,262 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $314,438 | 104,465 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $129,273 | 68,039 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $89,231 | 62,840 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,022 | 4,590 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,383 | 4,590 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,278 | 4,590 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,049 | 4,590 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $32,063 | 25,858 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $21,082 | 20,079 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $125,265 | 18,287 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $333,571 | 32,167 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $139,002 | 17,182 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $119,479 | 7,586 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $96,170 | 6,110 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $88,324 | 6,327 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $686,340 | 39,811 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $476,882 | 32,798 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,169,882 | 120,549 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,509 | 1,111 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $35,027 | 1,390 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $213,095 | 32,936 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,127 | 1,217 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,621 | 2,236 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $54,444 | 52,350 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||